XML 28 R87.htm IDEA: XBRL DOCUMENT v3.2.0.727
Supplemental Guarantor Financial Information (Details 4) - USD ($)
$ in Thousands
 6 Months Ended
May. 18, 2015
Feb. 17, 2015
Nov. 17, 2014
Aug. 18, 2014
May. 16, 2014
Mar. 28, 2014
Jun. 30, 2015
Jun. 30, 2014
Cash flows from operating activities:                
Net cash provided by (used in) continuing operations             $ 185,961 $ 120,137
Net cash provided by discontinued operations             1,351 2,466
Net cash provided by operating activities             187,312 122,603
Cash flows from investing activities:                
Capital expenditures             (254,180) (238,210)
Proceeds from sale of property, plant and equipment             19,348 13,399
Payment for business acquisition               (360,521)
Increase in restricted cash               (245)
Return of investments in non-consolidated affiliates             10,068 9,799
Proceeds received from settlement of note receivable             5,357  
Cash invested in non-consolidated affiliates               (197)
Net cash used in continuing operations             (219,407) (575,975)
Net cash provided by discontinued operations             16,560 33,276
Net cash used in investing activities             (202,847) (542,699)
Cash flows from financing activities:                
Proceeds from borrowings of long-term debt             765,500 1,389,799
Repayments of long-term debt             (703,000) (1,051,000)
Payments for debt issuance costs             (1,311) (6,923)
Payments above face value for redemption of convertible debt               (15,007)
Payments for settlement of interest rate swaps that include financing elements             (1,877) (1,894)
Net proceeds from the sale of Partnership units             1,268 169,471
Proceeds from stock options exercised             1,005 10,767
Proceeds from stock issued pursuant to our employee stock purchase plan             910 897
Purchases of treasury stock             (3,736) (6,315)
Dividends to Exterran stockholders $ (10,400) $ (10,300) $ (10,300) $ (10,000) $ (10,000) $ (10,000) (20,743) (19,990)
Stock-based compensation excess tax benefit             2,379 7,820
Distributions to noncontrolling partners in the Partnership             (40,491) (35,291)
Net cash provided by (used in) financing activities             (96) 442,334
Effect of exchange rate changes on cash and cash equivalents             (783) (4,000)
Net increase (decrease) in cash and cash equivalents             (16,414) 18,238
Cash and cash equivalents at beginning of period             39,739 35,665
Cash and cash equivalents at end of period             23,325 53,903
Eliminations                
Cash flows from investing activities:                
Capital distributions received from consolidated subsidiaries             (30,735) (26,641)
Investment in consolidated subsidiaries               11,128
Return of investments in consolidated subsidiaries             (20,743) (252,482)
Net cash used in continuing operations             (51,478) (267,995)
Net cash used in investing activities             (51,478) (267,995)
Cash flows from financing activities:                
Distributions to noncontrolling partners in the Partnership             30,735 26,641
Net proceeds from issuance of general partner units               (3,573)
Capital distributions to affiliates             20,743 252,482
Capital contributions received from parent               (7,555)
Net cash provided by (used in) financing activities             51,478 267,995
Parent | Reportable Legal Entities                
Cash flows from operating activities:                
Net cash provided by (used in) continuing operations             (1,607) (7,624)
Net cash provided by operating activities             (1,607) (7,624)
Cash flows from investing activities:                
Return of investments in consolidated subsidiaries             20,743 252,482
Net cash used in continuing operations             20,743 252,482
Net cash used in investing activities             20,743 252,482
Cash flows from financing activities:                
Proceeds from borrowings of long-term debt             518,500 825,001
Repayments of long-term debt             (537,500) (769,500)
Payments above face value for redemption of convertible debt               (15,007)
Proceeds from stock options exercised             1,005 10,767
Proceeds from stock issued pursuant to our employee stock purchase plan             910 897
Purchases of treasury stock             (3,736) (6,315)
Dividends to Exterran stockholders             (20,743) (19,990)
Stock-based compensation excess tax benefit             2,379 7,820
Borrowings (repayments) between consolidated subsidiaries, net             20,044 (278,461)
Net cash provided by (used in) financing activities             (19,141) (244,788)
Net increase (decrease) in cash and cash equivalents             (5) 70
Cash and cash equivalents at beginning of period             42 11
Cash and cash equivalents at end of period             37 81
Guarantor Subsidiaries | Reportable Legal Entities                
Cash flows from operating activities:                
Net cash provided by (used in) continuing operations             (3,412) 20,896
Net cash provided by operating activities             (3,412) 20,896
Cash flows from investing activities:                
Capital expenditures             (65,335) (69,033)
Proceeds from sale of property, plant and equipment             2,964 7,271
Payment for business acquisition               (9,400)
Capital distributions received from consolidated subsidiaries             30,735 26,641
Investment in consolidated subsidiaries               (11,128)
Net cash used in continuing operations             (31,636) (55,649)
Net cash used in investing activities             (31,636) (55,649)
Cash flows from financing activities:                
Capital distributions to affiliates             (20,743) (252,482)
Borrowings (repayments) between consolidated subsidiaries, net             56,222 295,227
Net cash provided by (used in) financing activities             35,479 42,745
Net increase (decrease) in cash and cash equivalents             431 7,992
Cash and cash equivalents at beginning of period             655 1,554
Cash and cash equivalents at end of period             1,086 9,546
Other Subsidiaries | Reportable Legal Entities                
Cash flows from operating activities:                
Net cash provided by (used in) continuing operations             190,980 106,865
Net cash provided by discontinued operations             1,351 2,466
Net cash provided by operating activities             192,331 109,331
Cash flows from investing activities:                
Capital expenditures             (188,845) (169,177)
Proceeds from sale of property, plant and equipment             16,384 6,128
Payment for business acquisition               (351,121)
Increase in restricted cash               (245)
Return of investments in non-consolidated affiliates             10,068 9,799
Proceeds received from settlement of note receivable             5,357  
Cash invested in non-consolidated affiliates               (197)
Net cash used in continuing operations             (157,036) (504,813)
Net cash provided by discontinued operations             16,560 33,276
Net cash used in investing activities             (140,476) (471,537)
Cash flows from financing activities:                
Proceeds from borrowings of long-term debt             247,000 564,798
Repayments of long-term debt             (165,500) (281,500)
Payments for debt issuance costs             (1,311) (6,923)
Payments for settlement of interest rate swaps that include financing elements             (1,877) (1,894)
Net proceeds from the sale of Partnership units             1,268 169,471
Distributions to noncontrolling partners in the Partnership             (71,226) (61,932)
Net proceeds from issuance of general partner units               3,573
Capital contributions received from parent               7,555
Borrowings (repayments) between consolidated subsidiaries, net             (76,266) (16,766)
Net cash provided by (used in) financing activities             (67,912) 376,382
Effect of exchange rate changes on cash and cash equivalents             (783) (4,000)
Net increase (decrease) in cash and cash equivalents             (16,840) 10,176
Cash and cash equivalents at beginning of period             39,042 34,100
Cash and cash equivalents at end of period             $ 22,202 $ 44,276